Intervention Insights to Present at Boston Oncology Investor Conference 2019

Share Article

Intervention Insights, a health-technology company focused on resolving the complexities of precision medicine announced today that CEO Clynt Taylor will present its molecular testing platform, Trapelo, at the Boston Oncology Investor Conference on Friday, March 15 at 9:30am ET.

Trapelo is the first decision-support technology to align oncologists, labs and payers around the most effective treatment path for patients to speed care when time matters most.

Trapelo is the first, single platform used by oncologists, labs and payers to enable decision support at the point of care in real time. Taylor will discuss the current disparities in the marketplace and share how Trapelo’s collaborative platform enables the scalable use of precision medicine with reimbursement from the start. The event takes place in the company’s hometown at 28 State Street, Boston, MA.

About Intervention Insights
Intervention Insights is an information technology company on a mission to address the challenges that result from rapid changes in the science, technology and business of next-generation cancer care. Its product, Trapelo, is a win-win solution for doctors, labs and payers that need real-time, evidence-based information and full transparency to make patient-based decisions. Trapelo is also the lead sponsor of the Precision Medicine Podcast, a media platform that brings together industry leaders to help accelerate the effective use of precision medicine for cancer care.

About Boston Oncology Investor Conference 2019
Organized by OneMed Forum, The Boston Oncology Investor Conference at Cowen Healthcare Week is sponsored by the National Foundation for Cancer Research, the International Cancer Impact Fund, Klosters Innovation Partners, McDermott Will & Emery, Torreya Partners, and Marcum. The meeting includes leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, startup public and private cancer companies, and cancer foundations for a discussion of trends, opportunities, and risks in oncology investing, corporate presentations by a select group of public and private oncology companies, and updates on cutting edge science. For more information about the conference, please refer to the conference website.

Media contact:
Karan Cushman, CMO, Intervention Insights kcushman(at)interventioninsights.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karan Cushman

Clynt Taylor
@PMPbyTrapelo
since: 12/2018
Follow >
Follow us on
Visit website